申请人:Ligand Pharmaceuticals Incorporated
公开号:US20020183346A1
公开(公告)日:2002-12-05
This invention relates to non-steroidal tricyclic compounds that are modulators of androgen receptors and to methods for making and using such compounds.
这项发明涉及非甾体三环化合物,这些化合物是雄激素受体的调节剂,并涉及制备和使用这些化合物的方法。